• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国超声心动图学会关于超声造影剂在超声心动图临床应用的共识声明。

American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography.

作者信息

Mulvagh Sharon L, Rakowski Harry, Vannan Mani A, Abdelmoneim Sahar S, Becher Harald, Bierig S Michelle, Burns Peter N, Castello Ramon, Coon Patrick D, Hagen Mary E, Jollis James G, Kimball Thomas R, Kitzman Dalane W, Kronzon Itzhak, Labovitz Arthur J, Lang Roberto M, Mathew Joseph, Moir W Stuart, Nagueh Sherif F, Pearlman Alan S, Perez Julio E, Porter Thomas R, Rosenbloom Judy, Strachan G Monet, Thanigaraj Srihari, Wei Kevin, Woo Anna, Yu Eric H C, Zoghbi William A

机构信息

Mayo Clinic, Rochester, MN, USA.

出版信息

J Am Soc Echocardiogr. 2008 Nov;21(11):1179-201; quiz 1281. doi: 10.1016/j.echo.2008.09.009.

DOI:10.1016/j.echo.2008.09.009
PMID:18992671
Abstract

UNLABELLED

ACCREDITATION STATEMENT: The American Society of Echocardiography (ASE) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The ASE designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit.trade mark Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Registry of Diagnostic Medical Sonographers and Cardiovascular Credentialing International recognize the ASE's certificates and have agreed to honor the credit hours toward their registry requirements for sonographers. The ASE is committed to resolving all conflict-of-interest issues, and its mandate is to retain only those speakers with financial interests that can be reconciled with the goals and educational integrity of the educational program. Disclosure of faculty and commercial support sponsor relationships, if any, have been indicated.

TARGET AUDIENCE

This activity is designed for all cardiovascular physicians, cardiac sonographers, and nurses with a primary interest and knowledge base in the field of echocardiography; in addition, residents, researchers, clinicians, sonographers, and other medical professionals having a specific interest in contrast echocardiography may be included.

OBJECTIVES

Upon completing this activity, participants will be able to: 1. Demonstrate an increased knowledge of the applications for contrast echocardiography and their impact on cardiac diagnosis. 2. Differentiate the available ultrasound contrast agents and ultrasound equipment imaging features to optimize their use. 3. Recognize the indications, benefits, and safety of ultrasound contrast agents, acknowledging the recent labeling changes by the US Food and Drug Administration (FDA) regarding contrast agent use and safety information. 4. Identify specific patient populations that represent potential candidates for the use of contrast agents, to enable cost-effective clinical diagnosis. 5. Incorporate effective teamwork strategies for the implementation of contrast agents in the echocardiography laboratory and establish guidelines for contrast use. 6. Use contrast enhancement for endocardial border delineation and left ventricular opacification in rest and stress echocardiography and unique patient care environments in which echocardiographic image acquisition is frequently challenging, including intensive care units (ICUs) and emergency departments. 7. Effectively use contrast echocardiography for the diagnosis of intracardiac and extracardiac abnormalities, including the identification of complications of acute myocardial infarction. 8. Assess the common pitfalls in contrast imaging and use stepwise, guideline-based contrast equipment setup and contrast agent administration techniques to optimize image acquisition.

摘要

未标注

认证声明:美国超声心动图学会(ASE)经继续医学教育认证委员会认可,可为医生提供继续医学教育。ASE将此教育活动指定为最多1个美国医学协会(AMA)PRA第1类学分。医师应仅根据其参与活动的程度申报学分。美国诊断医学超声医师注册处和心血管认证国际组织认可ASE的证书,并同意认可这些学分小时数,以满足其对超声医师注册要求。ASE致力于解决所有利益冲突问题,其任务是仅保留那些其经济利益与教育项目的目标和教育完整性相协调的演讲者。已注明教员与商业支持赞助商之间的关系(如有)。

目标受众

本活动面向所有对超声心动图领域有主要兴趣和知识基础的心血管内科医生、心脏超声医师和护士;此外,可能包括对超声心动图造影有特定兴趣的住院医师、研究人员、临床医生、超声医师和其他医学专业人员。

目标

完成本活动后,参与者将能够:1. 展示对超声心动图造影应用及其对心脏诊断影响的更多了解。2. 区分可用的超声造影剂和超声设备成像特征,以优化其使用。3. 认识超声造影剂的适应症、益处和安全性,了解美国食品药品监督管理局(FDA)最近关于造影剂使用和安全信息的标签更改。4. 识别代表使用造影剂潜在候选人群的特定患者群体,以实现具有成本效益的临床诊断。5. 纳入在超声心动图实验室实施造影剂的有效团队合作策略,并制定造影剂使用指南。6. 在静息和负荷超声心动图以及超声心动图图像采集经常具有挑战性的独特患者护理环境(包括重症监护病房(ICU)和急诊科)中,使用造影剂增强来勾勒心内膜边界和使左心室显影。7. 有效地使用超声心动图造影诊断心内和心外异常,包括识别急性心肌梗死的并发症。8. 评估造影成像中的常见陷阱,并使用基于指南的逐步造影设备设置和造影剂给药技术来优化图像采集。

相似文献

1
American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography.美国超声心动图学会关于超声造影剂在超声心动图临床应用的共识声明。
J Am Soc Echocardiogr. 2008 Nov;21(11):1179-201; quiz 1281. doi: 10.1016/j.echo.2008.09.009.
2
CME/CNE Article: A Framework of Care in Multiple Sclerosis, Part 1: Updated Disease Classification and Disease-Modifying Therapy Use in Specific Circumstances.继续医学教育/继续护理学教育文章:多发性硬化症的护理框架,第1部分:更新的疾病分类及特定情况下疾病修正治疗的应用
Int J MS Care. 2016 Nov-Dec;18(6):314-323. doi: 10.7224/1537-2073.2016-051.
3
Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.意大利心血管超声学会(SIEC)关于超声造影技术现状的共识会议
Ital Heart J. 2004 Apr;5(4):309-34.
4
Contrast echocardiography: current and future applications.对比超声心动图:当前及未来应用
J Am Soc Echocardiogr. 2000 Apr;13(4):331-42. doi: 10.1067/mje.2000.105462.
5
Clinical application and laboratory protocols for performing contrast echocardiography.进行超声心动图造影的临床应用及实验室操作规范。
Indian Heart J. 2013 May-Jun;65(3):337-46. doi: 10.1016/j.ihj.2013.04.002. Epub 2013 Apr 6.
6
Home study course: spring 2009.家庭学习课程:2009年春季
J Low Genit Tract Dis. 2009 Apr;13(2):120-4. doi: 10.1097/LGT.0b013e3181a129e9.
7
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
8
Home study course: spring 2007.家庭学习课程:2007年春季。
J Low Genit Tract Dis. 2007 Apr;11(2):123-6. doi: 10.1097/lgt.0b013e3180380fd3.
9
Guidelines for cardiac sonographer education: recommendations of the American Society of Echocardiography Sonographer Training and Education Committee.心脏超声检查技师教育指南:美国超声心动图学会超声检查技师培训与教育委员会的建议
J Am Soc Echocardiogr. 2001 Jan;14(1):77-84. doi: 10.1067/mje.2001.109922.
10
The Value of Quality Improvement Process in the Detection and Correction of Common Errors in Echocardiographic Hemodynamic Parameters in a Busy Echocardiography Laboratory.质量改进流程在繁忙的超声心动图实验室检测和纠正超声心动图血流动力学参数常见错误中的价值
Echocardiography. 2015 Dec;32(12):1778-89. doi: 10.1111/echo.12976. Epub 2015 Jun 1.

引用本文的文献

1
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for Definity.一项针对Definity的FDA不良事件报告系统(FAERS)事件的真实世界药物警戒研究。
PLoS One. 2025 Aug 29;20(8):e0331444. doi: 10.1371/journal.pone.0331444. eCollection 2025.
2
Advances in the Molecular Imaging of Sarcoma: An Emphasis on Metabolic Imaging.肉瘤分子成像的进展:重点关注代谢成像。
Mol Imaging Biol. 2025 Aug 19. doi: 10.1007/s11307-025-02045-w.
3
How to Perform Cardiac Contrast-Enhanced Ultrasound (cCEUS): Part I.如何进行心脏对比增强超声检查(cCEUS):第一部分。
Diagnostics (Basel). 2025 Jul 9;15(14):1743. doi: 10.3390/diagnostics15141743.
4
Standardizing Safety Practices for Contrast Enhanced Ultrasound in Radiology.规范放射学中超声造影的安全操作规范
J Ultrasound Med. 2025 Jun 24. doi: 10.1002/jum.16752.
5
Contemporary Safety of Ultrasound Enhancing Agents in a Nationwide Analysis.全国性分析中超声增强剂的当代安全性
J Am Heart Assoc. 2025 May 20;14(10):e039480. doi: 10.1161/JAHA.124.039480. Epub 2025 May 14.
6
Diagnostic characteristics of multimodality imaging for left ventricular lipoma: new insights on surgical intervention.左心室脂肪瘤的多模态成像诊断特征:手术干预的新见解
Cardiovasc Ultrasound. 2025 Mar 28;23(1):11. doi: 10.1186/s12947-025-00346-2.
7
Multi-societal expert consensus statement on the safe administration of ultrasound contrast agents.关于超声造影剂安全使用的多学会专家共识声明。
Echo Res Pract. 2025 Feb 21;12(1):4. doi: 10.1186/s44156-024-00068-7.
8
Effect of combined Zhuang medicine treatment on tricuspid annular displacement and heart rate variability in rheumatoid arthritis patients.壮医药联合治疗对类风湿关节炎患者三尖瓣环位移及心率变异性的影响
Am J Transl Res. 2024 Jul 15;16(7):2953-2962. doi: 10.62347/NHTG3720. eCollection 2024.
9
The intersection of heart failure and cancer in women: a review.女性心力衰竭与癌症的交集:综述
Front Cardiovasc Med. 2024 Feb 28;11:1276141. doi: 10.3389/fcvm.2024.1276141. eCollection 2024.
10
The value of ultrasound enhancing agents in the echocardiographic acquisition of pulmonary artery systolic pressure: An invasive to non-invasive correlation study.超声增强剂在超声心动图获取肺动脉收缩压中的价值:一项有创与无创相关性研究。
Int J Cardiovasc Imaging. 2024 Apr;40(4):821-830. doi: 10.1007/s10554-024-03051-9. Epub 2024 Jan 18.